We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-0.34%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$31B
AUM Growth
-$2.5B
Cap. Flow
-$2.32B
Cap. Flow %
-7.47%
Top 10 Hldgs %
35.64%
Holding
459
New
27
Increased
98
Reduced
274
Closed
16

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$372M
2
CSCO icon
Cisco
CSCO
+$301M
3
WMT icon
Walmart Inc
WMT
+$273M
4
PBYI icon
Puma Biotechnology
PBYI
+$258M
5
IBM icon
IBM
IBM
+$248M

Sector Composition

Rank Sector Weight
1 Technology 23.69%
2 Healthcare 21.74%
3 Consumer Staples 15.63%
4 Consumer Discretionary 13.48%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVV icon
401
Ovintiv
OVV
$16.6B
$432K ﹤0.01%
7,840
GILD icon
402
Gilead Sciences
GILD
$162B
$421K ﹤0.01%
3,600
-1,000
-22% -$109K
HTLD icon
403
Heartland Express
HTLD
$1.06B
$401K ﹤0.01%
19,800
-27,100
-58% -$581K
OII icon
404
Oceaneering
OII
$5.19B
$391K ﹤0.01%
8,400
AXIA
405
AXIA Energia
AXIA
$22.9B
$385K ﹤0.01%
+258,755
New +$448K
MRK icon
406
Merck
MRK
$323B
$370K ﹤0.01%
6,812
-2,538
-27% -$142K
ZD icon
407
Ziff Davis
ZD
$1.93B
$353K ﹤0.01%
5,980
-8,280
-58% -$490K
VALE.P
408
DELISTED
Vale S A
VALE.P
$329K ﹤0.01%
65,200
-886,663
-93% -$4.95M
AGN
409
DELISTED
Allergan plc
AGN
$312K ﹤0.01%
1,029
-262,590
-100% -$78.3M
CI icon
410
Cigna
CI
$77B
$292K ﹤0.01%
1,800
-400
-18% -$55.3K
DLB icon
411
Dolby
DLB
$4.85B
$290K ﹤0.01%
7,300
-10,100
-58% -$400K
SYNT
412
DELISTED
Syntel Inc
SYNT
$288K ﹤0.01%
6,076
-8,400
-58% -$401K
LBTYK icon
413
Liberty Global Class C
LBTYK
$3.27B
$285K ﹤0.01%
6,959
NOV icon
414
NOV
NOV
$7.35B
$276K ﹤0.01%
5,724
+860
+18% +$44.2K
GYRO icon
415
Gyrodyne
GYRO
$12.5M
$274K ﹤0.01%
+8,341
New +$324K
WDC icon
416
Western Digital
WDC
$172B
$274K ﹤0.01%
+4,625
New +$331K
SBUX icon
417
Starbucks
SBUX
$118B
$258K ﹤0.01%
4,814
UGP icon
418
Ultrapar
UGP
$6.71B
$248K ﹤0.01%
23,560
ITT icon
419
ITT
ITT
$17.7B
$246K ﹤0.01%
5,883
-737
-11% -$30.7K
MEOH icon
420
Methanex
MEOH
$4.19B
$245K ﹤0.01%
4,409
+78
+2% +$4.4K
LYB icon
421
LyondellBasell Industries
LYB
$18.9B
$244K ﹤0.01%
2,353
-1,280
-35% -$129K
ASC icon
422
Ardmore Shipping
ASC
$669M
$243K ﹤0.01%
+20,095
New +$235K
HAL icon
423
Halliburton
HAL
$26.8B
$241K ﹤0.01%
5,600
-300
-5% -$13.8K
ABEV icon
424
Ambev
ABEV
$47.4B
$240K ﹤0.01%
+39,400
New +$243K
UAL icon
425
United Airlines
UAL
$39.1B
$239K ﹤0.01%
4,507
+1,207
+37% +$69.9K

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2015 Portfolio in Review

As of Q2 2015, Grantham, Mayo, Van Otterloo & Co (GMO) held 459 positions worth $31B, down 7.4% from $33.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $2.32B in Q2 2015, closing 16 positions and reducing 274 holdings. Its most notable exit was LORILLARD INC COM STK, an estimated $68.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Puma Biotechnology worth $167M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2015 buy was Puma Biotechnology: 1,426,738 shares worth $167M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Microsoft in Q2 2015, an estimated $372M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2015 reduction was Express Scripts Holding Company, cutting an estimated $909M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $68.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 36% of its $31B portfolio in Q2 2015.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 27 new positions and closed 16 in Q2 2015.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 7.4% quarter-over-quarter to $31B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2015, filed 13 Aug 2015.